Ending Physician Speaker Programs May Not Be A Good Thing

Law360, New York (March 11, 2014, 6:36 PM EDT) -- With GlaxoSmithKline PLC's December 2013 announcement that it would stop recruiting and paying physicians to conduct promotional programming for their pharmaceutical products, many have questioned when, or whether, other companies will follow GSK's lead. Interestingly, fewer people appear to be asking whether GSK’s decision marks a positive development in advancing the public health and reducing actual or potential conflicts of interest. Or is the GSK decision just another sign that government enforcement activities are driving companies to further minimize their legal risks by cutting programs and...
To view the full article, register now.